全文获取类型
收费全文 | 2146篇 |
免费 | 150篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 79篇 |
妇产科学 | 46篇 |
基础医学 | 217篇 |
口腔科学 | 58篇 |
临床医学 | 304篇 |
内科学 | 496篇 |
皮肤病学 | 41篇 |
神经病学 | 89篇 |
特种医学 | 251篇 |
外国民族医学 | 1篇 |
外科学 | 237篇 |
综合类 | 60篇 |
预防医学 | 176篇 |
眼科学 | 46篇 |
药学 | 150篇 |
中国医学 | 1篇 |
肿瘤学 | 86篇 |
出版年
2021年 | 25篇 |
2020年 | 20篇 |
2019年 | 25篇 |
2018年 | 34篇 |
2017年 | 34篇 |
2016年 | 28篇 |
2015年 | 51篇 |
2014年 | 74篇 |
2013年 | 129篇 |
2012年 | 106篇 |
2011年 | 87篇 |
2010年 | 56篇 |
2009年 | 59篇 |
2008年 | 63篇 |
2007年 | 112篇 |
2006年 | 78篇 |
2005年 | 86篇 |
2004年 | 65篇 |
2003年 | 61篇 |
2002年 | 58篇 |
2001年 | 85篇 |
2000年 | 66篇 |
1999年 | 50篇 |
1998年 | 40篇 |
1997年 | 37篇 |
1996年 | 41篇 |
1995年 | 37篇 |
1994年 | 28篇 |
1993年 | 28篇 |
1992年 | 47篇 |
1991年 | 46篇 |
1990年 | 39篇 |
1989年 | 52篇 |
1988年 | 36篇 |
1987年 | 37篇 |
1986年 | 30篇 |
1985年 | 27篇 |
1984年 | 25篇 |
1983年 | 25篇 |
1982年 | 13篇 |
1981年 | 13篇 |
1980年 | 18篇 |
1979年 | 19篇 |
1976年 | 22篇 |
1975年 | 20篇 |
1974年 | 13篇 |
1973年 | 20篇 |
1972年 | 20篇 |
1971年 | 16篇 |
1966年 | 13篇 |
排序方式: 共有2348条查询结果,搜索用时 15 毫秒
1.
Joseph F. Levy Rahul Khairnar Alexander V. Louie Timothy N. Showalter C. Daniel Mullins Mark V. Mishra 《Practical radiation oncology》2019,9(2):e172-e179
Purpose
A hydrogel rectal spacer (HRS) is a medical device that is approved by the U.S. Food and Drug Administration to increase the separation between the prostate and rectum. We conducted a cost-effectiveness analysis of HRS use for reduction in radiation therapy (RT) toxicities in patients with prostate cancer (PC) undergoing external beam RT (EBRT).Methods and Materials
A multistate Markov model was constructed from the U.S. payer perspective to examine the cost-effectiveness of HRS in men with localized PC receiving EBRT (EBRT alone vs EBRT + HRS). The subgroups analyzed included site of HRS placement (hospital outpatient, physician office, ambulatory surgery center) and proportion of patients with good baseline erectile function (EF). Data on EF, gastrointestinal and genitourinary toxicities incidence, and potential risks associated with HRS implantation were obtained from a recently published randomized clinical trial. Health utilities and costs were derived from the literature and the 2018 Physician Fee Schedule and were discounted 3% annually. Quality-adjusted life years (QALYs) and costs were modeled for a 5-year period from receipt of RT. Probabilistic sensitivity analysis and value-based threshold analyses were conducted.Results
The per-patient 5-year incremental cost for spacers administered in a hospital outpatient setting was $3578, and the incremental effectiveness was 0.0371 QALYs. The incremental cost-effectiveness ratio was $96,440/QALY for patients with PC undergoing HRS insertion in a hospital and $39,286/QALY for patients undergoing HRS insertion in an ambulatory facility. For men with good baseline EF, the incremental cost-effectiveness ratio was $35,548/QALY and $9627/QALY in hospital outpatient and ambulatory facility settings, respectively.Conclusions
Based on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision-making. 相似文献2.
Gary E. Stapleton Benjamin W. Eidem Ricardo H. Pignatelli Karina M. Carlson Charles E. Mullins Ronald G. Grifka 《Congenital heart disease》2006,1(3):116-119
Background. A persistent patent ductus arteriosus (PDA) may delay closure of a coexisting atrial septal defect (ASD) due to volume loading and enlargement of the left atrium. The purpose of this study was to investigate the natural history of ASD size in patients with a PDA following transcatheter PDA occlusion. Methods. All patients with an ASD and a PDA who underwent transcatheter PDA occlusion at Texas Children’s Hospital were identified. Patients with ASD diameter <3 mm, or additional cardiac defects were excluded. Eight patients (7 females) with small‐ to moderate‐sized ASDs and a PDA were identified. Patient demographics, echocardiographic data, and cardiac catheterization data were recorded. Data were analyzed by 1‐tailed t‐test. Results. Following PDA occlusion, ASD diameter decreased in 6 of 8 patients by a mean of 3.8 mm (±2.3 mm), including 2 that closed. The median duration of follow‐up was 689 days. One ASD remained unchanged and 1 increased in size. The mean maximum ASD diameter decreased from 6.4 mm (±2.2 mm) to 3.9 mm (±3.4 mm) (P = .03). Two patients underwent subsequent transcatheter ASD occlusion. Conclusion. Following transcatheter PDA occlusion, small‐ to moderate‐sized ASDs have significant probability to decrease in size, and possibly close. In infants and children, we recommend transcatheter PDA occlusion, and serial follow‐up of the size of the ASD. This will allow many small‐ to moderate‐sized ASDs to either close, or become smaller, obviating the need for future intervention. 相似文献
3.
氟喹诺酮类药物不良反应168例分析 总被引:12,自引:0,他引:12
0 引言 随着氟喹诺酮类药物在临床的广泛应用,有关其应用所致不良反应的报道也日趋增多,我们通过对1990/2003年我院氟喹诺酮类药物不良反应情况报告如下,供临床参考。 相似文献
4.
Pressure ulcers are a high-risk, high-volume, and high-cost problem for persons with disabilities. This article describes four tools published in the literature and reports the validity, reliability, strengths, and limitations of each. These tools include the Pressure Ulcer Scale for Healing (PUSH), the Pressure Sore Status Tool (PSST), the Sussman Wound Healing Tool (SWHT), and the Sessing Scale. Rehabilitation nurses should use a consistent framework with accurate quantification to assess, document, and monitor changes in pressure ulcers over time. Such a measurement tool must prove valid for the disabled population in which the tool is used. This will enable healthcare providers to communicate more effectively and evaluate the therapeutic plan of care. 相似文献
5.
Factors influencing women to undergo screening mammography 总被引:2,自引:0,他引:2
6.
7.
8.
The morphologic distinction between thyroid carcinoma and certain benign thyroid conditions can be difficult in selected cases. P-glycoprotein (Pgp), a glycoprotein associated with tumor multidrug resistance, has been reported to be expressed in thyroid carcinoma but not in benign thyroid conditions. To determine the specificity of immunostaining for Pgp in the diagnosis of thyroid carcinoma, we studied formalin-fixed, paraffin-embedded tissue from 69 cases of various thyroid lesions using a commercially available monoclonal antibody to Pgp (C219, Centocor, Malvern, PA) and an avidin-biotin-peroxidase complex technique. Positive reactivity was seen in 15 of 37 (41%) benign thyroid conditions and in 23 of 32 (72%) thyroid carcinomas. We conclude that immunostaining for Pgp is not specific in the diagnosis of thyroid carcinoma. 相似文献
9.
Friction, capacitance and transepidermal water loss (TEWL) in dry atopic and normal skin 总被引:2,自引:0,他引:2
MARIE LODÉN HÅKAN OLSSON TONY AXÉLL YLVA WERNER LINDE† 《The British journal of dermatology》1992,126(2):137-141
The biophysical properties of non-eczematous skin at three locations in atopics and non-atopics were characterized using non-invasive physical methods. Skin friction was measured with a newly developed sliding friction instrument, the degree of hydration with a capacitance meter (Corneometer CM 820), and the transepidermal water loss (TEWL) was determined using an Evaporimeter EP1. The areas examined (dorsum of the hand, volar forearm and lower back) showed lower values of friction and capacitance in the atopic patients than did corresponding sites in the normal controls. In most areas a significant correlation between friction and capacitance was found. The TEWL was increased in atopic skin, but TEWL seems to correlate neither to friction nor to capacitance. 相似文献
10.